![Lena Elisabeth Svanberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lena Elisabeth Svanberg
Directeur/Membre du Conseil chez
EGETIS THERAPEUTICS AB
Fortune : 42 528 $ au 31/07/2026
Profil
Dr. Lena Elisabeth Svanberg is a Partner at Ventac Partners GmbH, a Chief Medical Officer at Kuste Biopharma SAS, an Independent Director at Egetis Therapeutics AB and a Chief Development Officer at IXALTIS SAS. She is on the Board of Directors at Leo Pharma, Inc., Amolyt Pharma SAS, Egetis Therapeutics AB, Epics Therapeutics SA and LEO Pharma A/S.
Dr. Svanberg was previously employed as a Chairman by Pharnext SA, an Independent Non-Executive Director by Galapagos NV, an Independent Director by Swedish Orphan Biovitrum AB, a VP & Head-Established Products Group by Janssen Pharmaceuticals, Inc., and a Head-Medical Affairs by Bristol Myers Squibb Co. She also served on the board at Follicum AB and The Swedish-American Chamber of Commerce, Inc. She received her doctorate degree from the University of Gothenburg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 37 676 ( 0,01% ) | 23 696 $ | 31/07/2026 | |
| 31/12/2025 | 686 ( 0% ) | 18 832 $ | 31/07/2026 |
Postes actifs de Lena Elisabeth Svanberg
| Sociétés | Poste | Début |
|---|---|---|
| EGETIS THERAPEUTICS AB | Directeur/Membre du Conseil | 01/01/2017 |
IXALTIS SAS
 IXALTIS SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2016 |
Amolyt Pharma SAS
 Amolyt Pharma SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical & natural sciences | Directeur/Membre du Conseil | 30/06/2021 |
Kuste Biopharma SAS
 Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Develops therapies for unmet medical inflammatory | Directeur Technique/Scientifique/R&D | 01/01/2020 |
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Directeur/Membre du Conseil | - |
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Directeur/Membre du Conseil | - |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Directeur/Membre du Conseil | 01/01/2022 |
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Offers life sciences consultancy services | Corporate Officer/Principal | 01/01/2023 |
Anciens postes connus de Lena Elisabeth Svanberg
| Sociétés | Poste | Fin |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Directeur/Membre du Conseil | 01/11/2025 |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Lena Elisabeth Svanberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
University of Gothenburg
 University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharnext SA
 Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Retail Trade |
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Offers life sciences consultancy services | Commercial Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Follicum AB
 Follicum AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for the treatment of hair-loss | Health Technology |
The Swedish-American Chamber of Commerce, Inc.
 The Swedish-American Chamber of Commerce, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a corporation membership organization | Commercial Services |
Amolyt Pharma SAS
Amolyt Pharma SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical & natural sciences | Commercial Services |
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
Kuste Biopharma SAS
Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Develops therapies for unmet medical inflammatory | Health Technology |
